Madison, Wisconsin-based Propeller Health has closed a $21.5 million Series C financing round, with new investors 3M Ventures, S.R. One, Limited and Hikma Ventures, plus existing investors Safeguard Scientifics and Social Capital. The funding will be used to further Propeller’s digitally-guided therapy platform.
Propeller’s aim is to simplify management of chronic respiratory diseases like asthma and COPD through sensors that attached to inhalers and sync to a companion app. The digitally-guided therapy platform is able to integrate with multiple sources, including connected medications, and uses machine learning to design a personalized therapy plan for each user.
{iframe}http://www.mobihealthnews.com/content/propeller-health-raises-215m-digitally-guided-respiratory-therapy-platform{/iframe}